Although isolated adrenocorticotropin (ACTH) deficiency (IAD) is a heterogeneous disorder with several etiologies, the majority of acquired cases are most likely due to an autoimmune process [1] [2] [3] . Painless thyroiditis, which is considered a variant form of Hashimoto's thyroiditis, is characterized by transient thyrotoxicosis that is sometimes followed by transient hypothyroidism and then recovery [4] . Although acquired IAD is not uncommonly associated with other autoimmune endocrine disorders, especially Hashimoto's thyroiditis [5, 6] , reported cases of IAD associated with painless thyroiditis are scarce. Herein, we report a case of IAD associated with painless thyroiditis and briefly review the literature.
don reflex was slightly brisk. Neurological examinations revealed no other abnormalities.
Laboratory data obtained on admission are shown in Table 1 . Results indicated relative lymphocytosis, eosinophilia, and slight normocytic normochromic anemia. Serum level of aspartate aminotransferase was slightly elevated, while those of total protein, albumin, and total cholesterol were decreased. Slight hyponatremia and hyperphosphatemia were seen. Although anti-acetylcholine receptor antibody was negative, he tested positive for anti-nuclear antibody, rheumatoid factor, and anti-SS-A/Ro antibody. Chest X-ray and electrocardiogram were normal. Serum levels of free thyroxine (T4) and free triiodothyronine (T3) were elevated, while serum thyrotropin (TSH) was suppressed. The patient was positive for both antithyroid peroxidase and anti-thyroglobulin antibodies, but was negative for both TSH-binding inhibitor immunoglobulin and thyroid-stimulating antibody. Thyroidal iodine-123 uptake was markedly decreased (0.5% /3h, and 1.1% /24h). Ultrasonography revealed a diffusely swollen thyroid with low echogenicity. Because the patient's general malaise was so remarkable and he had slight eosinophilia, adrenal insufficiency was suspected. Plasma ACTH and serum cortisol were undetectable, as was urinary free cortisol. The results of a combined anterior pituitary stimulation test are provided in Table 2 (Table 3) . Antipituitary antibodies against GH3 cells (rat GH and prolactin secreting cell) and AtT-20 cells (mouse ACTH secreting cell) were negative when tested using immunofluorescence [7] . Magnetic resonance imaging (MRI) of the pituitary gland did not show any abnormalities.
The patient was diagnosed as having IAD associated with painless thyroiditis. Treatment with 12.5 mg/day cortisone acetate quickly relieved his symptoms of malaise and myalgia. After 4 weeks of glucocorticoid therapy, he experienced transient hypothyroidism. The lowest serum free T4 was 0.3 ng/dL and the highest serum TSH was 57.3 μIU/mL during the episode. Finally, 3 months after his first visit, the patient became spontaneously euthyroid. Currently, 2 years after his first visit, he continues to do well on 20 mg/ day hydrocortisone. His thyroid function has remained normal over the past 2 years, and he has not experienced any recurrence of painless thyroiditis. Laboratory results indicate that plasma ACTH and serum cortisol are still undetectable. Although the patient's serum levels of GH and prolactin were slightly elevated on admission, serum levels of GH, insulin like growth factor-1, and prolactin were all within the normal ranges.
DISCUSSION
The majority of acquired IAD cases are thought to result from an autoimmune mechanism, as suggested by the presence of anti-pituitary antibodies in some patients with IAD, cases with lymphocytic hypophysitis that are complicated with IAD, and the frequent association of IAD and other autoimmune endocrine disorders [1] [2] [3] . Although the present patient had several autoantibodies, anti-pituitary antibodies were not detected. It has been reported that 21-48% of patients with IAD had anti-pituitary antibodies in their serum, as determined by a variety of assays [7, 8] , and that anti-pituitary antibodies might disappear during the course of the disease [9] . The present patient had no medical or family history of adrenal insufficiency, and had not experienced head trauma. MRI of the pituitary gland revealed no abnormalities. Although the patient tested negative for anti-pituitary antibodies, an autoimmune mechanism is presumed to have caused the dysfunction or destruction of corticotrophs in the present patient. The present patient also had Hashimoto's thyroiditis, as indicated by the diffuse goiter and positive tests for anti-thyroid antibodies. Both Murakami et al. [10] and Hashimoto [6] have reported literature reviews about IAD associated with thyroid disorders in Japan. According to Murakami et al.'s review of 103 cases, 13 cases (12.6%) were positive for anti-thyroid antibodies. More than half of the IAD cases had high plasma levels of TSH that were either basal or TRHinduced. On the other hand, of the 304 cases Hashimoto [6] reviewed, 88 (28.9%) were associated with thyroid disorders, including Hashimoto's thyroiditis (39 cases, 12.8%), primary hypothyroidism (34 cases, 11.1%), hyperthyroidism (4 cases, 1.3%), and destructive thyroiditis (2 cases, 0.7%).
In contrast to the common association of IAD and Hashimoto's thyroiditis, reported cases of IAD associated with painless thyroiditis are scarce. We performed a literature review with PubMed (for English literature), Ichushi (by the non-profit Japan Medical Abstracts Society), and the Internet database of abstracts from regional meetings of the Japanese Society of Internal Medicine. We used the keywords "isolated adrenocorticotropin deficiency" and "thyroiditis". Twenty-four cases, including the present case, of IAD associated with painless thyroiditis have been reported in the English and Japanese literature ( Table 4 ). The age of these patients ranged from 30 to 73 years (mean 54±10 years), and there were 13 men and 11 women. Seven patients were diagnosed with IAD more than 5 months before the onset of painless thyroiditis. With the exception of these 7 cases, the period between onset of symptoms and the diagnosis of IAD with painless thyroiditis ranged between 1 and 4 months. In almost all of the cases, patients reported appetite loss, general fatigue and/or weight loss as chief complaints. Two patients were diagnosed with painless thyroiditis 3-4 months postpartum (Cases 8 and 18 ). MRI revealed empty sella in 3 of 17 cases. Most cases had either Hashimoto's thyroiditis or serum anti-thyroid antibodies, while 2 of 10 cases had anti-pituitary antibodies. The present patient was diagnosed with painless thyroiditis 3 months after the development of transient headache followed by general fatigue and weight loss. The thyrotoxic phase of painless thyroiditis typically lasts 2-9 weeks before subsiding [34] . Based on the natural clinical course of painless thyroiditis, the disorder is presumed to have developed after or at nearly the same time as adrenal insufficiency due to IAD in the present patient, as in most of the previously reported cases.
The present patient had a history of ocular myasthenia gravis which had been in remission following thymectomy 30 years ago. Autoimmune thyroid disease occurs in 4-8% of patients with myasthenia gravis [35, 36] . However, the literature search with PubMed, Ichushi, and the abstract database of regional meetings provided by the Japanese Society of Internal Medicine revealed only one case of IAD associated with myasthenia gravis [37] . That case was a Caucasian female who had undergone thymectomy for myasthenia graves 4 years before the onset of IAD. Thymectomy is one of the treatment options for myasthenia gravis. Systemic autoimmune disorders including systemic lupus erythematosus, Hashimoto's thyroiditis, pure red cell aplasia, and idiopathic portal hypertension may occur many years after thymectomy in patients with myasthenia gravis [38, 39] . Although the role of thymectomy in the onset of autoimmune disorders in patients with myasthenia gravis remains unclear, this sequence of events may be induced by altered regulatory T cell homeostasis [40] . Thus, thymectomy might have facilitated the development of pituitary and thyroid autoimmunity in the present patient.
It is likely that thyrotoxicosis due to painless thyroiditis aggravates the symptoms of insidious adrenal insufficiency in patients with IAD. Thyroid hormones increase the metabolic clearance of cortisol by increasing hepatic Δ4,5-steroid reductase activity in the liver [41] . The precise timing of IAD onset is uncertain in the majority of cases, and the clinical course of IAD is heterogeneous. Like type 1A diabetes mellitus, the onset of IAD may be abrupt, acute, or slowly progressive. The associated increase in thyroid hormone levels can uncover adrenal insufficiency or precipitate adrenal crises in patients with compensated chronic or relative hypoadrenalism [20, 42] .
Several reports describe the effect of decreases in the serum glucocorticoid levels on the development of painless thyroiditis. Painless thyroiditis may occur after an acute cessation of steroid therapy in patients with rheumatoid arthritis [43] or allergic rhinitis [44] , after an adrenalectomy in patients with Cushing's syndrome [45] , or after hypopituitarism following pituitary apoplexy [46] . Moreover, there are reports of the ACTH DEFICIENCY AND PAINLESS THYROIDITIS [47] . Glucocorticoids exert an important modulatory role on the immune system, and inappropriately low glucocorticoid levels predispose patients to autoimmune and inflammatory diseases [48] . Thus, hypoadrenocorticism-induced immunological changes could trigger the development of painless thyroiditis.
In conclusion, painless thyroiditis is one of the endocrinological complications of IAD patients with Hashimoto's thyroiditis. Thyrotoxicosis due to painless thyroiditis uncovers insidious adrenal insufficiency caused by IAD. However, hypoadrenocorticism-induced immunological changes may also trigger the development of painless thyroiditis.
